Dianthus Therapeutics, Inc.

NASDAQ:DNTH

Biotechnology

Healthcare
$84.83 -1.25%

-$1.03 today

Market cap
$4.78B
Beta
0.07
P/E (TTM)
-343.0
EPS (TTM)
-$0.24
52W Low $16.64High $96.50

Volume 0.89M

Average 0.82M

Price history

Dianthus Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+110.03%

Period high

$115.96

Period low

$36.20

Latest

$84.83

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 12, 2026Nov 12, 2026
10-QNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
SC 13GOct 30, 2026Oct 30, 2026
4Sep 18, 2026Sep 18, 2026
S-3ASRSep 18, 2026Sep 18, 2026
4Sep 3, 2026Sep 3, 2026
4Aug 19, 2026Aug 19, 2026
4Aug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 13, 2026Aug 13, 2026
4Aug 11, 2026Aug 11, 2026
4Aug 11, 2026Aug 11, 2026
4Aug 11, 2026Aug 11, 2026
4Aug 7, 2026Aug 7, 2026

Competitors

Who does Dianthus Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DNTH's filings, answered from its disclosures.

What is the latest DNTH filing?

The latest filing shown is 4 dated Nov 12, 2026.

How many recent filings does DNTH have?

Intrinsic Alpha currently shows 20 recent filings for DNTH.